TreeWAS – Variant ID: rs16830728

Hospitalization Episode Statistics (HES)

Self-Reported Statistics (SRS)

Hierarchical visualisation How to interpret this figure?

Showing all nodes without filtering.

Click on a node to zoom (except terminal nodes).

Download this figure in format

Results table

Term	Risk posterior probability	No effect posterior probability	Protective posterior probability
N94.6 Dysmenorrhoea, unspecified	0.019	0.981	0.000
N94.9 Unspecified condition associated with female genital organs and menstrual cycle	0.014	0.985	0.000
N94 Pain and other conditions associated with female genital organs and menstrual cycle	0.014	0.986	0.000
H50.1 Divergent concomitant strabismus	0.014	0.986	0.000
H50 Other strabismus	0.013	0.987	0.000
N94.8 Other specified conditions associated with female genital organs and menstrual cycle	0.012	0.988	0.000
H50.0 Convergent concomitant strabismus	0.012	0.988	0.000
H50.9 Strabismus, unspecified	0.012	0.988	0.000
N94.3 Premenstrual tension syndrome	0.011	0.989	0.000
T36-T50 Poisoning by drugs, medicaments and biological substances	0.011	0.989	0.000
T42 Poisoning by antiepileptic, sedative-hypnotic and anti-Parkinsonism drugs	0.011	0.989	0.000
T39 Poisoning by nonopioid analgesics, antipyretics and antirheumatics	0.011	0.989	0.000
N94.5 Secondary dysmenorrhoea	0.010	0.989	0.000
N94.2 Vaginismus	0.010	0.989	0.000
N94.0 Mittelschmerz	0.010	0.989	0.000
T42.6 Other antiepileptic and sedative-hypnotic drugs	0.011	0.989	0.000
T50 Poisoning by diuretics and other and unspecified drugs, medicaments and biological substances	0.010	0.989	0.000
T50.9 Other and unspecified drugs, medicaments and biological substances	0.010	0.990	0.000
M47.82 Other spondylosis (Cervical region)	0.000	0.990	0.010
T45 Poisoning by primarily systemic and haematological agents, not elsewhere classified	0.010	0.990	0.000
T43 Poisoning by psychotropic drugs, not elsewhere classified	0.010	0.990	0.000
T39.3 Other nonsteroidal anti-inflammatory drugs [NSAID]	0.010	0.990	0.000
H50.2 Vertical strabismus	0.009	0.990	0.000
H50.8 Other specified strabismus	0.009	0.991	0.000
H50.6 Mechanical strabismus	0.009	0.991	0.000
H50.5 Heterophoria	0.009	0.991	0.000
H50.4 Other and unspecified heterotropia	0.009	0.991	0.000
H50.3 Intermittent heterotropia	0.009	0.991	0.000
N94.4 Primary dysmenorrhoea	0.009	0.991	0.000
T45.0 Antiallergic and antiemetic drugs	0.009	0.991	0.000
T37 Poisoning by other systemic anti-infectives and antiparasitics	0.009	0.991	0.000
T39.0 Salicylates	0.009	0.991	0.000
T42.1 Iminostilbenes	0.009	0.991	0.000
T39.1 4-Aminophenol derivatives	0.009	0.991	0.000
T44 Poisoning by drugs primarily affecting the autonomic nervous system	0.009	0.991	0.000
T39.8 Other nonopioid analgesics and antipyretics, not elsewhere classified	0.008	0.992	0.000
T49 Poisoning by topical agents primarily affecting skin and mucous membrane and by ophthalmological, otorhinolarygological and dental drugs	0.008	0.992	0.000
T48 Poisoning by agents primarily acting on smooth and skeletal muscles and the respiratory system	0.008	0.992	0.000
T41 Poisoning by anaesthetics and therapeutic gases	0.008	0.992	0.000
T43.2 Other and unspecified antidepressants	0.008	0.992	0.000
T42.4 Benzodiazepines	0.008	0.992	0.000
T42.8 Anti-Parkinsonism drugs and other central muscle-tone depressants	0.008	0.992	0.000
T42.7 Antiepileptic and sedative-hypnotic drugs, unspecified	0.008	0.992	0.000
T42.5 Mixed antiepileptics, not elsewhere classified	0.008	0.992	0.000
T42.3 Barbiturates	0.008	0.992	0.000
T42.2 Succinimides and oxazolidinediones	0.008	0.992	0.000
T42.0 Hydantoin derivatives	0.008	0.992	0.000
T40 Poisoning by narcotics and psychodysleptics [hallucinogens]	0.008	0.992	0.000
T43.3 Phenothiazine antipsychotics and neuroleptics	0.008	0.992	0.000
T39.9 Nonopioid analgesic, antipyretic and antirheumatic, unspecified	0.008	0.992	0.000
T39.4 Antirheumatics, not elsewhere classified	0.008	0.992	0.000
T39.2 Pyrazolone derivatives	0.008	0.992	0.000
T36 Poisoning by systemic antibiotics	0.008	0.992	0.000
L27.0 Generalised skin eruption due to drugs and medicaments	0.008	0.992	0.000
T50.8 Diagnostic agents	0.008	0.992	0.000
T50.7 Analeptics and opioid receptor antagonists	0.008	0.992	0.000
T50.6 Antidotes and chelating agents, not elsewhere classified	0.008	0.992	0.000
T50.5 Appetite depressants	0.008	0.992	0.000
T50.4 Drugs affecting uric acid metabolism	0.008	0.992	0.000
T50.3 Electrolytic, caloric and water-balance agents	0.008	0.992	0.000
T50.2 Carbonic-anhydrase inhibitors, benzothiadiazides and other diuretics	0.008	0.992	0.000
T50.1 Loop [high-ceiling] diuretics	0.008	0.992	0.000
T50.0 Mineralocorticoids and their antagonists	0.008	0.992	0.000
T47 Poisoning by agents primarily affecting gastro-intestinal system	0.008	0.992	0.000
T43.6 Psychostimulants with abuse potential	0.007	0.992	0.000
T37.8 Other specified systemic anti-infectives and antiparasitics	0.007	0.993	0.000
T45.9 Primarily systemic and haematological agent, unspecified	0.007	0.993	0.000
T45.8 Other primarily systemic and haematological agents	0.007	0.993	0.000
T45.7 Anticoagulant antagonists, vitamin K and other coagulants	0.007	0.993	0.000
T45.6 Fibrinolysis-affecting drugs	0.007	0.993	0.000
T45.4 Iron and its compounds	0.007	0.993	0.000
T45.3 Enzymes, not elsewhere classified	0.007	0.993	0.000
T45.2 Vitamins, not elsewhere classified	0.007	0.993	0.000
T45.1 Antineoplastic and immunosuppressive drugs	0.007	0.993	0.000
T43.9 Psychotropic drug, unspecified	0.007	0.993	0.000
T43.8 Other psychotropic drugs, not elsewhere classified	0.007	0.993	0.000
T43.4 Butyrophenone and thioxanthene neuroleptics	0.007	0.993	0.000
T43.1 Monoamine-oxidase-inhibitor antidepressants	0.007	0.993	0.000
T38 Poisoning by hormones and their synthetic substitutes and antagonists, not elsewhere classified	0.007	0.993	0.000
T45.5 Anticoagulants	0.007	0.993	0.000
T43.5 Other and unspecified antipsychotics and neuroleptics	0.007	0.993	0.000
T44.3 Other parasympatholytics [anticholinergics and antimuscarines] and spasmolytics, not elsewhere classified	0.007	0.993	0.000
T43.0 Tricyclic and tetracyclic antidepressants	0.007	0.993	0.000
T37.9 Systemic anti-infective and antiparasitic, unspecified	0.007	0.993	0.000
T37.5 Antiviral drugs	0.007	0.993	0.000
T37.4 Anthelminthics	0.007	0.993	0.000
T37.3 Other antiprotozoal drugs	0.007	0.993	0.000
T37.2 Antimalarials and drugs acting on other blood protozoa	0.007	0.993	0.000
T37.1 Antimycobacterial drugs	0.007	0.993	0.000
T37.0 Sulphonamides	0.007	0.993	0.000
T44.7 Beta-Adrenoreceeptor antagonists, not elsewhere classified	0.006	0.993	0.000
T44.9 Other and unspecified drugs primarily affecting the nervous system	0.006	0.993	0.000
T44.8 Centrally acting and afrenergic-neuron-blocking agents, not elsewhere classified	0.006	0.993	0.000
T44.6 Alpha-Adrenoreceeptor antagonists, not elsewhere classified	0.006	0.993	0.000
T44.5 Predominantly Beta-adrenoreceptor agonists, not elsewhere classified	0.006	0.993	0.000
T44.4 Predominantly Alpha-adrenoreceptor agonists, not elsewhere classified	0.006	0.993	0.000
T44.2 Ganglionic blocking drugs, not elsewhere classified	0.006	0.993	0.000
T44.1 Other parasympathomimetics [cholinergics]	0.006	0.993	0.000
T44.0 Anticholinesterase agents	0.006	0.993	0.000
T46 Poisoning by agents primarily affecting the cardiovascular system	0.006	0.994	0.000
T40.2 Other opioids	0.006	0.994	0.000
T41.5 Therapeutic gases	0.006	0.994	0.000
T41.4 Anaesthetic, unspecified	0.006	0.994	0.000
T41.3 Local anaesthetics	0.006	0.994	0.000
T41.2 Other and unspecified general anaesthetics	0.006	0.994	0.000
T41.1 Intravenous anaesthetics	0.006	0.994	0.000
T41.0 Inhaled anaesthetics	0.006	0.994	0.000
T48.7 Other and unspecified agents primarily acting on the respiratory system	0.006	0.994	0.000
T48.6 Antiasthmatics, not elsewhere classified	0.006	0.994	0.000
T48.5 Anti-common-cold drugs	0.006	0.994	0.000
T48.4 Expectorants	0.006	0.994	0.000
T48.3 Antitussives	0.006	0.994	0.000
T48.2 Other and unspecified agents primarily acting on muscles	0.006	0.994	0.000
T48.1 Skeletal muscle relaxants [neuromuscular blocking agents]	0.006	0.994	0.000
T48.0 Oxytocic drugs	0.006	0.994	0.000
T49.9 Topical agent, unspecified	0.006	0.994	0.000
T49.8 Other topical agents	0.006	0.994	0.000
T49.7 Dental drugs, topically applied	0.006	0.994	0.000
T49.6 Otorhinolaryngological drugs and preparations	0.006	0.994	0.000
T49.5 Ophthalmological drugs and preparations	0.006	0.994	0.000
T49.4 Keratolytics, keratoplastics and other hair treatment drugs and preparations	0.006	0.994	0.000
T49.3 Emollients, demulcents and protectants	0.006	0.994	0.000
T49.2 Local astringents and local detergents	0.006	0.994	0.000
T49.1 Antipruritics	0.006	0.994	0.000
T49.0 Local antifungal, anti-infective and anti-inflammatory drugs, not elsewhere classified	0.006	0.994	0.000
N41.1 Chronic prostatitis	0.006	0.994	0.000
N94.1 Dyspareunia	0.006	0.994	0.000
T40.9 Other and unspecified psychodysleptics [hallucinogens]	0.006	0.994	0.000
T40.8 Lysergide [LSD]	0.006	0.994	0.000
T40.7 Cannabis (derivatives)	0.006	0.994	0.000
T40.5 Cocaine	0.006	0.994	0.000
T40.3 Methadone	0.006	0.994	0.000
T40.1 Heroin	0.006	0.994	0.000
T40.0 Opium	0.006	0.994	0.000
I50.9 Heart failure, unspecified	0.000	0.994	0.006
N41.9 Inflammatory disease of prostate, unspecified	0.006	0.994	0.000
T36.9 Systemic antibiotic, unspecified	0.006	0.994	0.000
T36.8 Other systemic antibiotics	0.006	0.994	0.000
T36.7 Antifungal antibiotics, systemically used	0.006	0.994	0.000
T36.6 Rifamycins	0.006	0.994	0.000
T36.5 Aminoglycosides	0.006	0.994	0.000
T36.4 Tetracyclines	0.006	0.994	0.000
T36.3 Macrolides	0.006	0.994	0.000
T36.2 Chloramphenicol group	0.006	0.994	0.000
T36.1 Cefalosporins and other Beta-lactam antibiotics	0.006	0.994	0.000
T40.4 Other synthetic narcotics	0.006	0.994	0.000
T40.6 Other and unspecified narcotics	0.006	0.994	0.000
T36.0 Penicillins	0.006	0.994	0.000
T47.9 Agent primarily affecting the gastro-intestinal system, unspecified	0.006	0.994	0.000
T47.8 Other agents primarily affecting the gastro-intestinal system	0.006	0.994	0.000
T47.7 Emetics	0.006	0.994	0.000
T47.6 Antidiarrhoeal drugs	0.006	0.994	0.000
T47.5 Digestants	0.006	0.994	0.000
T47.4 Other laxatives	0.006	0.994	0.000
T47.3 Saline and osmotic laxatives	0.006	0.994	0.000
T47.2 Stimulant laxatives	0.006	0.994	0.000
T47.0 Histamine H(2)-receptor antagonists	0.006	0.994	0.000
E83.4 Disorders of magnesium metabolism	0.000	0.994	0.006
M48.06 Spinal stenosis (Lumbar region)	0.000	0.994	0.006
N41 Inflammatory diseases of prostate	0.006	0.994	0.000
E83.3 Disorders of phosphorus metabolism	0.000	0.994	0.006
T38.9 Other and unspecified hormone antagonists	0.005	0.995	0.000
T38.8 Other and unspecified hormones and their synthetic substitutes	0.005	0.995	0.000
T38.7 Androgens and anabolic congeners	0.005	0.995	0.000
T38.6 Antigonadotrophins. antioestrogens, antiandrogens, not elsewhere classified	0.005	0.995	0.000
T38.5 Other oestrogens and progestogens	0.005	0.995	0.000
T38.4 Oral contraceptives	0.005	0.995	0.000
T38.2 Antithyroid drugs	0.005	0.995	0.000
T38.1 Thyroid hormones and substitutes	0.005	0.995	0.000
T38.0 Glucocorticoids and synthetic analogues	0.005	0.995	0.000
N35.9 Urethral stricture, unspecified	0.005	0.995	0.000
T47.1 Other antacids and anti-gastric-secretion drugs	0.005	0.995	0.000
N41.0 Acute prostatitis	0.005	0.995	0.000
T46.1 Calcium-channel blockers	0.005	0.995	0.000
T46.9 Other and unspecified agents primarily affecting the cardiovascular system	0.005	0.995	0.000
T46.8 Antivaricose drugs, including sclerosing agents	0.005	0.995	0.000
T46.7 Peripheral vasodilators	0.005	0.995	0.000
T46.5 Other antihypertensive drugs, not elsewhere classified	0.005	0.995	0.000
T46.3 Coronary vasodilators, not elsewhere classified	0.005	0.995	0.000
T46.2 Other antidysrhythmic drugs, not elsewhere classified	0.005	0.995	0.000
T46.0 Cardiac-stimulant glycosides and drugs of similar action	0.005	0.995	0.000
E83 Disorders of mineral metabolism	0.000	0.995	0.005
F10.2 Dependence syndrome	0.000	0.995	0.005
L27 Dermatitis due to substances taken internally	0.005	0.995	0.000
M48.0 Spinal stenosis	0.000	0.995	0.005
E83.1 Disorders of iron metabolism	0.000	0.996	0.004
M79.09 Rheumatism, unspecified (Site unspecified)	0.004	0.996	0.000
T38.3 Insulin and oral hypoglycaemic [antidiabetic] drugs	0.004	0.996	0.000
M48.02 Spinal stenosis (Cervical region)	0.000	0.996	0.004
N41.8 Other inflammatory diseases of prostate	0.004	0.996	0.000
N41.3 Prostatocystitis	0.004	0.996	0.000
N41.2 Abscess of prostate	0.004	0.996	0.000
K14.9 Disease of tongue, unspecified	0.004	0.996	0.000
L27.1 Localised skin eruption due to drugs and medicaments	0.004	0.996	0.000
M48.00 Spinal stenosis (Multiple sites in spine)	0.000	0.996	0.004
T46.6 Antihyperlipidaemic and antiarteriosclerotic drugs	0.004	0.996	0.000
T46.4 Angiotensin-converting-enzyme inhibitors	0.003	0.996	0.000
E83.9 Disorder of mineral metabolism, unspecified	0.000	0.996	0.004
E83.8 Other disorders of mineral metabolism	0.000	0.996	0.004
E83.2 Disorders of zinc metabolism	0.000	0.996	0.004
E83.0 Disorders of copper metabolism	0.000	0.996	0.004
K07.3 Anomalies of tooth position	0.004	0.996	0.000
Z29.0 Isolation	0.004	0.996	0.000
M48.09 Spinal stenosis (Site unspecified)	0.000	0.996	0.004
L27.9 Dermatitis due to unspecified substance taken internally	0.004	0.996	0.000
L27.8 Dermatitis due to other substances taken internally	0.004	0.996	0.000
L27.2 Dermatitis due to ingested food	0.004	0.996	0.000
Z29.1 Prophylactic immunotherapy	0.004	0.996	0.000
F10 Mental and behavioural disorders due to use of alcohol	0.000	0.996	0.004
M48.08 Spinal stenosis (Sacral and sacrococcygeal region)	0.000	0.996	0.003
M48.05 Spinal stenosis (Thoracolumbar region)	0.000	0.996	0.003
M48.04 Spinal stenosis (Thoracic region)	0.000	0.996	0.003
M48.03 Spinal stenosis (Cervicothoracic region)	0.000	0.996	0.003
M48.01 Spinal stenosis (Occipito-atlanto-axial region)	0.000	0.996	0.003
O70.1 Second degree perineal laceration during delivery	0.000	0.996	0.004
Z29 Need for other prophylactic measures	0.004	0.996	0.000
Z29.2 Other prophylactic chemotherapy	0.003	0.997	0.000
G83.4 Cauda equina syndrome	0.003	0.997	0.000
F10.0 Acute intoxication	0.000	0.997	0.003
F10.4 Withdrawal state with delirium	0.000	0.997	0.003
M79.00 Rheumatism, unspecified (Multiple sites)	0.003	0.997	0.000
M79.0 Rheumatism, unspecified	0.003	0.997	0.000
E85.9 Amyloidosis, unspecified	0.003	0.997	0.000
F10.9 Unspecified mental and behavioural disorder	0.000	0.997	0.003
F10.8 Other mental and behavioural disorders	0.000	0.997	0.003
F10.7 Residual and late-onset psychotic disorder	0.000	0.997	0.003
F10.6 Amnesic syndrome	0.000	0.997	0.003
F10.5 Psychotic disorder	0.000	0.997	0.003
K14 Diseases of tongue	0.003	0.997	0.000
M48.07 Spinal stenosis (Lumbosacral region)	0.000	0.997	0.003
G83 Other paralytic syndromes	0.003	0.997	0.000
F10.3 Withdrawal state	0.000	0.997	0.003
G83.1 Monoplegia of lower limb	0.003	0.997	0.000
Z29.9 Prophylactic measure, unspecified	0.003	0.997	0.000
F10.1 Harmful use	0.000	0.997	0.003
M48 Other spondylopathies	0.000	0.997	0.003
N35 Urethral stricture	0.003	0.997	0.000
A08.4 Viral intestinal infection, unspecified	0.000	0.997	0.003
E85.4 Organ-limited amyloidosis	0.003	0.997	0.000
H80.9 Otosclerosis, unspecified	0.003	0.997	0.000
Z29.8 Other specified prophylactic measures	0.003	0.997	0.000
G83.2 Monoplegia of upper limb	0.003	0.997	0.000
K14.8 Other diseases of tongue	0.003	0.997	0.000
G83.8 Other specified paralytic syndromes	0.002	0.997	0.000
E89.0 Postprocedural hypothyroidism	0.000	0.997	0.003
K80.0 Calculus of gallbladder with acute cholecystitis	0.002	0.998	0.000
L89.9 Decubitus ulcer and pressure area, unspecified	0.000	0.998	0.002
E85 Amyloidosis	0.002	0.998	0.000
M79.08 Rheumatism, unspecified (Other)	0.002	0.998	0.000
M79.07 Rheumatism, unspecified (Ankle and foot)	0.002	0.998	0.000
M79.06 Rheumatism, unspecified (Lower leg)	0.002	0.998	0.000
M79.05 Rheumatism, unspecified (Pelvic region and thigh)	0.002	0.998	0.000
M79.04 Rheumatism, unspecified (Hand)	0.002	0.998	0.000
M79.03 Rheumatism, unspecified (Forearm)	0.002	0.998	0.000
M79.02 Rheumatism, unspecified (Upper arm)	0.002	0.998	0.000
M79.01 Rheumatism, unspecified (Shoulder region)	0.002	0.998	0.000
A04.5 Campylobacter enteritis	0.000	0.998	0.002
K14.0 Glossitis	0.002	0.998	0.000
L98.0 Pyogenic granuloma	0.002	0.998	0.000
N35.8 Other urethral stricture	0.002	0.998	0.000
H49-H52 Disorders of ocular muscles, binocular movement, accommodation and refraction	0.002	0.998	0.000
M06.95 Rheumatoid arthritis, unspecified (Pelvic region and thigh)	0.002	0.998	0.000
G83.9 Paralytic syndrome, unspecified	0.002	0.998	0.000
K14.6 Glossodynia	0.002	0.998	0.000
K14.5 Plicated tongue	0.002	0.998	0.000
K14.4 Atrophy of tongue papillae	0.002	0.998	0.000
K14.3 Hypertrophy of tongue papillae	0.002	0.998	0.000
K14.2 Median rhomboid glossitis	0.002	0.998	0.000
K14.1 Geographic tongue	0.002	0.998	0.000
E83.5 Disorders of calcium metabolism	0.000	0.998	0.002
G83.5 Locked-in syndrome	0.002	0.998	0.000
G83.3 Monoplegia, unspecified	0.002	0.998	0.000
G83.0 Diplegia of upper limbs	0.002	0.998	0.000
M48.9 Spondylopathy, unspecified	0.000	0.998	0.002
M48.8 Other specified spondylopathies	0.000	0.998	0.002
M48.4 Fatigue fracture of vertebra	0.000	0.998	0.002
M48.3 Traumatic spondylopathy	0.000	0.998	0.002
M48.2 Kissing spine	0.000	0.998	0.002
M48.1 Ankylosing hyperostosis [Forestier]	0.000	0.998	0.002
N35.1 Postinfective urethral stricture, not elsewhere classified	0.002	0.998	0.000
N35.0 Posttraumatic urethral stricture	0.002	0.998	0.000
E85.3 Secondary systemic amyloidosis	0.002	0.998	0.000
M48.5 Collapsed vertebra, not elsewhere classified	0.000	0.998	0.002
S00.9 Superficial injury of head, part unspecified	0.000	0.998	0.002
A08.1 Acute gastro-enteropathy due to Norwalk agent	0.000	0.998	0.002
A08 Viral and other specified intestinal infections	0.000	0.998	0.002
D25.0 Submucous leiomyoma of uterus	0.000	0.998	0.002
M06.97 Rheumatoid arthritis, unspecified (Ankle and foot)	0.002	0.998	0.000
M06.90 Rheumatoid arthritis, unspecified (Multiple sites)	0.002	0.998	0.000
M48.56 Collapsed vertebra, not elsewhere classified (Lumbar region)	0.000	0.998	0.002
B37.8 Candidiasis of other sites	0.000	0.998	0.002
E85.8 Other amyloidosis	0.002	0.998	0.000
E85.2 Heredofamilial amyloidosis, unspecified	0.002	0.998	0.000
E85.1 Neuropathic heredofamilial amyloidosis	0.002	0.998	0.000
E85.0 Nonneuropathic heredofamilial amyloidosis	0.002	0.998	0.000
S00.2 Other superficial injuries of eyelid and periocular area	0.000	0.998	0.002
M06.9 Rheumatoid arthritis, unspecified	0.002	0.998	0.000
H51 Other disorders of binocular movement	0.002	0.998	0.000
M45.X9 Ankylosing spondylitis (Site unspecified)	0.000	0.998	0.002
S00.8 Superficial injury of other parts of head	0.000	0.998	0.002
B37.0 Candidal stomatitis	0.000	0.998	0.002
K05.6 Periodontal disease, unspecified	0.002	0.998	0.000
L89.1 Stage II decubitus ulcer	0.000	0.998	0.002
M06.92 Rheumatoid arthritis, unspecified (Upper arm)	0.002	0.998	0.000
M05.90 Seropositive rheumatoid arthritis, unspecified (Multiple sites)	0.002	0.998	0.000
M48.19 Ankylosing hyperostosis [Forestier] (Site unspecified)	0.000	0.998	0.002
M48.18 Ankylosing hyperostosis [Forestier] (Sacral and sacrococcygeal region)	0.000	0.998	0.002
M48.17 Ankylosing hyperostosis [Forestier] (Lumbosacral region)	0.000	0.998	0.002
M48.16 Ankylosing hyperostosis [Forestier] (Lumbar region)	0.000	0.998	0.002
M48.15 Ankylosing hyperostosis [Forestier] (Thoracolumbar region)	0.000	0.998	0.002
M48.14 Ankylosing hyperostosis [Forestier] (Thoracic region)	0.000	0.998	0.002
M48.13 Ankylosing hyperostosis [Forestier] (Cervicothoracic region)	0.000	0.998	0.002
M48.12 Ankylosing hyperostosis [Forestier] (Cervical region)	0.000	0.998	0.002
M48.11 Ankylosing hyperostosis [Forestier] (Occipito-atlanto-axial region)	0.000	0.998	0.002
M48.10 Ankylosing hyperostosis [Forestier] (Multiple sites in spine)	0.000	0.998	0.002
M48.29 Kissing spine (Site unspecified)	0.000	0.998	0.002
M48.28 Kissing spine (Sacral and sacrococcygeal region)	0.000	0.998	0.002
M48.27 Kissing spine (Lumbosacral region)	0.000	0.998	0.002
M48.26 Kissing spine (Lumbar region)	0.000	0.998	0.002
M48.25 Kissing spine (Thoracolumbar region)	0.000	0.998	0.002
M48.24 Kissing spine (Thoracic region)	0.000	0.998	0.002
M48.23 Kissing spine (Cervicothoracic region)	0.000	0.998	0.002
M48.22 Kissing spine (Cervical region)	0.000	0.998	0.002
M48.21 Kissing spine (Occipito-atlanto-axial region)	0.000	0.998	0.002
M48.20 Kissing spine (Multiple sites in spine)	0.000	0.998	0.002
M48.39 Traumatic spondylopathy (Site unspecified)	0.000	0.998	0.002
M48.38 Traumatic spondylopathy (Sacral and sacrococcygeal region)	0.000	0.998	0.002
M48.37 Traumatic spondylopathy (Lumbosacral region)	0.000	0.998	0.002
M48.36 Traumatic spondylopathy (Lumbar region)	0.000	0.998	0.002
M48.35 Traumatic spondylopathy (Thoracolumbar region)	0.000	0.998	0.002
M48.34 Traumatic spondylopathy (Thoracic region)	0.000	0.998	0.002
M48.33 Traumatic spondylopathy (Cervicothoracic region)	0.000	0.998	0.002
M48.32 Traumatic spondylopathy (Cervical region)	0.000	0.998	0.002
M48.31 Traumatic spondylopathy (Occipito-atlanto-axial region)	0.000	0.998	0.002
M48.30 Traumatic spondylopathy (Multiple sites in spine)	0.000	0.998	0.002
M48.49 Fatigue fracture of vertebra (Site unspecified)	0.000	0.998	0.002
M48.48 Fatigue fracture of vertebra (Sacral and sacrococcygeal region)	0.000	0.998	0.002
M48.47 Fatigue fracture of vertebra (Lumbosacral region)	0.000	0.998	0.002
M48.46 Fatigue fracture of vertebra (Lumbar region)	0.000	0.998	0.002
M48.45 Fatigue fracture of vertebra (Thoracolumbar region)	0.000	0.998	0.002
M48.44 Fatigue fracture of vertebra (Thoracic region)	0.000	0.998	0.002
M48.43 Fatigue fracture of vertebra (Cervicothoracic region)	0.000	0.998	0.002
M48.42 Fatigue fracture of vertebra (Cervical region)	0.000	0.998	0.002
M48.41 Fatigue fracture of vertebra (Occipito-atlanto-axial region)	0.000	0.998	0.002
M48.40 Fatigue fracture of vertebra (Multiple sites in spine)	0.000	0.998	0.002
M48.59 Collapsed vertebra, not elsewhere classified (Site unspecified)	0.000	0.998	0.002
M48.58 Collapsed vertebra, not elsewhere classified (Sacral and sacrococcygeal region)	0.000	0.998	0.002
M48.57 Collapsed vertebra, not elsewhere classified (Lumbosacral region)	0.000	0.998	0.002
M48.55 Collapsed vertebra, not elsewhere classified (Thoracolumbar region)	0.000	0.998	0.002
M48.53 Collapsed vertebra, not elsewhere classified (Cervicothoracic region)	0.000	0.998	0.002
M48.52 Collapsed vertebra, not elsewhere classified (Cervical region)	0.000	0.998	0.002
M48.51 Collapsed vertebra, not elsewhere classified (Occipito-atlanto-axial region)	0.000	0.998	0.002
M48.50 Collapsed vertebra, not elsewhere classified (Multiple sites in spine)	0.000	0.998	0.002
M48.89 Other specified spondylopathies (Site unspecified)	0.000	0.998	0.002
M48.88 Other specified spondylopathies (Sacral and sacrococcygeal region)	0.000	0.998	0.002
M48.87 Other specified spondylopathies (Lumbosacral region)	0.000	0.998	0.002
M48.86 Other specified spondylopathies (Lumbar region)	0.000	0.998	0.002
M48.85 Other specified spondylopathies (Thoracolumbar region)	0.000	0.998	0.002
M48.84 Other specified spondylopathies (Thoracic region)	0.000	0.998	0.002
M48.83 Other specified spondylopathies (Cervicothoracic region)	0.000	0.998	0.002
M48.82 Other specified spondylopathies (Cervical region)	0.000	0.998	0.002
M48.81 Other specified spondylopathies (Occipito-atlanto-axial region)	0.000	0.998	0.002
M48.80 Other specified spondylopathies (Multiple sites in spine)	0.000	0.998	0.002
M48.99 Spondylopathy, unspecified (Site unspecified)	0.000	0.998	0.002
M48.98 Spondylopathy, unspecified (Sacral and sacrococcygeal region)	0.000	0.998	0.002
M48.97 Spondylopathy, unspecified (Lumbosacral region)	0.000	0.998	0.002
M48.96 Spondylopathy, unspecified (Lumbar region)	0.000	0.998	0.002
M48.95 Spondylopathy, unspecified (Thoracolumbar region)	0.000	0.998	0.002
M48.94 Spondylopathy, unspecified (Thoracic region)	0.000	0.998	0.002
M48.93 Spondylopathy, unspecified (Cervicothoracic region)	0.000	0.998	0.002
M48.92 Spondylopathy, unspecified (Cervical region)	0.000	0.998	0.002
M48.91 Spondylopathy, unspecified (Occipito-atlanto-axial region)	0.000	0.998	0.002
M48.90 Spondylopathy, unspecified (Multiple sites in spine)	0.000	0.998	0.002
C90.0 Multiple myeloma	0.002	0.998	0.000
K12.3 Oral mucositis (ulcerative)	0.002	0.998	0.000
T51.0 Ethanol	0.002	0.998	0.000
L89 Decubitus ulcer	0.000	0.998	0.002
J22 Unspecified acute lower respiratory infection	0.000	0.998	0.002
A08.5 Other specified intestinal infections	0.000	0.998	0.002
A08.3 Other viral enteritis	0.000	0.998	0.002
A08.2 Adenoviral enteritis	0.000	0.998	0.002
A08.0 Rotaviral enteritis	0.000	0.998	0.002
T83.5 Infection and inflammatory reaction due to prosthetic device, implant and graft in urinary system	0.002	0.998	0.000
K07 Dentofacial anomalies [including malocclusion]	0.002	0.998	0.000
K74.6 Other and unspecified cirrhosis of liver	0.000	0.998	0.002
A04 Other bacterial intestinal infections	0.000	0.998	0.002
B37 Candidiasis	0.000	0.998	0.002
T93.1 Sequelae of fracture of femur	0.002	0.998	0.000
S00 Superficial injury of head	0.000	0.998	0.002
M06.94 Rheumatoid arthritis, unspecified (Hand)	0.002	0.998	0.000
L89.0 Stage I decubitus ulcer and pressure area	0.000	0.998	0.002
M06.93 Rheumatoid arthritis, unspecified (Forearm)	0.002	0.998	0.000
B95.8 Unspecified staphylococcus as the cause of diseases classified to other chapters	0.000	0.998	0.002
L89.2 Stage III decubitus ulcer	0.000	0.998	0.002
S02.40 Fracture of malar and maxillary bones (closed)	0.000	0.998	0.002
J03.9 Acute tonsillitis, unspecified	0.002	0.998	0.000
T83.1 Mechanical complication of other urinary devices and implants	0.002	0.998	0.000
M45 Ankylosing spondylitis	0.000	0.998	0.002
M06.98 Rheumatoid arthritis, unspecified (Other)	0.002	0.998	0.000
S42.10 Fracture of scapula (closed)	0.000	0.998	0.002
H51.9 Disorder of binocular movement, unspecified	0.001	0.998	0.000
H51.8 Other specified disorders of binocular movement	0.001	0.998	0.000
H51.2 Internuclear ophthalmoplegia	0.001	0.998	0.000
H51.1 Convergence insufficiency and excess	0.001	0.998	0.000
H51.0 Palsy of conjugate gaze	0.001	0.998	0.000
M45.X0 Ankylosing spondylitis (Multiple sites in spine)	0.000	0.998	0.002
I50 Heart failure	0.000	0.998	0.002
I50.0 Congestive heart failure	0.000	0.998	0.002
O42.0 Premature rupture of membranes, onset of labour within 24 hours	0.000	0.998	0.002
H49 Paralytic strabismus	0.001	0.998	0.000
I84.1 Internal haemorrhoids with other complications	0.002	0.998	0.000
T83.0 Mechanical complication of urinary (indwelling) catheter	0.002	0.998	0.000
M06.96 Rheumatoid arthritis, unspecified (Lower leg)	0.002	0.998	0.000
M88.90 Paget's disease of bone, unspecified (Multiple sites)	0.002	0.998	0.000
E89.3 Postprocedural hypopituitarism	0.000	0.998	0.002
K07.4 Malocclusion, unspecified	0.002	0.998	0.000
M48.54 Collapsed vertebra, not elsewhere classified (Thoracic region)	0.000	0.998	0.001
L89.3 Stage IV decubitus ulcer	0.000	0.998	0.002
M05.97 Seropositive rheumatoid arthritis, unspecified (Ankle and foot)	0.002	0.998	0.000
T83 Complications of genito-urinary prosthetic devices, implants and grafts	0.002	0.998	0.000
C67.9 Bladder, unspecified	0.002	0.998	0.000
A04.9 Bacterial intestinal infection, unspecified	0.000	0.998	0.001
A04.6 Enteritis due to Yersinia enterocolitica	0.000	0.998	0.001
A04.4 Other intestinal Escherichia coli infections	0.000	0.998	0.001
A04.3 Enterohaemorrhagic Escherichia coli infection	0.000	0.998	0.001
A04.2 Enteroinvasive Escherichia coli infection	0.000	0.998	0.001
A04.1 Enterotoxigenic Escherichia coli infection	0.000	0.998	0.001
A04.0 Enteropathogenic Escherichia coli infection	0.000	0.998	0.001
H90.3 Sensorineural hearing loss, bilateral	0.000	0.998	0.002
K07.9 Dentofacial anomaly, unspecified	0.001	0.998	0.000
K07.8 Other dentofacial anomalies	0.001	0.998	0.000
K07.5 Dentofacial functional abnormalities	0.001	0.998	0.000
K07.2 Anomalies of dental arch relationship	0.001	0.998	0.000
K07.1 Anomalies of jaw-cranial base relationship	0.001	0.998	0.000
K07.0 Major anomalies of jaw size	0.001	0.998	0.000
S00.7 Multiple superficial injuries of head	0.000	0.998	0.002
E89 Postprocedural endocrine and metabolic disorders, not elsewhere classified	0.000	0.998	0.002
T51 Toxic effect of alcohol	0.002	0.998	0.000
A04.8 Other specified bacterial intestinal infections	0.000	0.998	0.002
B37.7 Candidal septicaemia	0.000	0.998	0.001
B37.6 Candidal endocarditis	0.000	0.998	0.001
B37.5 Candidal meningitis	0.000	0.998	0.001
B37.4 Candidiasis of other urogenital sites	0.000	0.998	0.001
B37.2 Candidiasis of skin and nail	0.000	0.998	0.001
S02.4 Fracture of malar and maxillary bones	0.000	0.998	0.002
S02.60 Fracture of mandible (closed)	0.000	0.998	0.002
B37.1 Pulmonary candidiasis	0.000	0.998	0.001
S00.4 Superficial injury of ear	0.000	0.998	0.001
S00.5 Superficial injury of lip and oral cavity	0.000	0.998	0.001
T83.6 Infection and inflammatory reaction due to prosthetic device, implant and graft in genital tract	0.001	0.998	0.000
H80 Otosclerosis	0.001	0.998	0.000
B37.3 Candidiasis of vulva and vagina	0.000	0.998	0.001
C77.9 Lymph node, unspecified	0.002	0.998	0.000
K45.8 Other specified abdominal hernia without obstruction or gangrene	0.002	0.998	0.000
O03.4 Incomplete, without complication	0.000	0.998	0.002
M45.X8 Ankylosing spondylitis (Sacral and sacrococcygeal region)	0.000	0.998	0.001
M45.X7 Ankylosing spondylitis (Lumbosacral region)	0.000	0.998	0.001
M45.X6 Ankylosing spondylitis (Lumbar region)	0.000	0.998	0.001
M45.X5 Ankylosing spondylitis (Thoracolumbar region)	0.000	0.998	0.001
M45.X4 Ankylosing spondylitis (Thoracic region)	0.000	0.998	0.001
M45.X3 Ankylosing spondylitis (Cervicothoracic region)	0.000	0.998	0.001
M45.X2 Ankylosing spondylitis (Cervical region)	0.000	0.998	0.001
M45.X1 Ankylosing spondylitis (Occipito-atlanto-axial region)	0.000	0.998	0.001
Z98.0 Intestinal bypass and anastomosis status	0.000	0.998	0.002
S02.10 Fracture of base of skull (closed)	0.000	0.998	0.001
B37.9 Candidiasis, unspecified	0.000	0.998	0.001
H49.9 Paralytic strabismus, unspecified	0.001	0.998	0.000
H49.8 Other paralytic strabismus	0.001	0.998	0.000
H49.4 Progressive external ophthalmoplegia	0.001	0.998	0.000
H49.3 Total (external) ophthalmoplegia	0.001	0.998	0.000
H49.1 Fourth [trochlear] nerve palsy	0.001	0.998	0.000
M05.9 Seropositive rheumatoid arthritis, unspecified	0.001	0.998	0.000
S51.9 Open wound of forearm, part unspecified	0.001	0.998	0.000
T83.8 Other complications of genito-urinary prosthetic devices, implants and grafts	0.001	0.998	0.000
S02.6 Fracture of mandible	0.000	0.998	0.001
S52.80 Fracture of other parts of forearm (closed)	0.001	0.999	0.000
A04.7 Enterocolitis due to Clostridium difficile	0.000	0.999	0.001
H49.0 Third [oculomotor] nerve palsy	0.001	0.999	0.000
M06.91 Rheumatoid arthritis, unspecified (Shoulder region)	0.001	0.999	0.000
S02.1 Fracture of base of skull	0.000	0.999	0.001
T83.4 Mechanical complication of other prosthetic devices, implants and grafts in genital tract	0.001	0.999	0.000
T83.9 Unspecified complication of genito-urinary prosthetic device, implant and graft	0.001	0.999	0.000
T83.2 Mechanical complication of graft of urinary organ	0.001	0.999	0.000
T58 Toxic effect of carbon monoxide	0.001	0.999	0.000
S00.0 Superficial injury of scalp	0.000	0.999	0.001
T51.8 Other alcohols	0.001	0.999	0.000
T51.3 Fusel oil	0.001	0.999	0.000
T51.2 2-Propanol	0.001	0.999	0.000
T51.1 Methanol	0.001	0.999	0.000
S02 Fracture of skull and facial bones	0.000	0.999	0.001
S02.41 Fracture of malar and maxillary bones (open)	0.000	0.999	0.001
A09.0 Other and unspecified gastroenteritis and colitis of infectious origin	0.001	0.999	0.000
E89.9 Postprocedural endocrine and metabolic disorder, unspecified	0.000	0.999	0.001
E89.8 Other postprocedural endocrine and metabolic disorders	0.000	0.999	0.001
E89.6 Postprocedural adrenocortical(-medullary) hypofunction	0.000	0.999	0.001
E89.5 Postprocedural testicular hypofunction	0.000	0.999	0.001
E89.4 Postprocedural ovarian failure	0.000	0.999	0.001
E89.1 Postprocedural hypoinsulinaemia	0.000	0.999	0.001
H90.5 Sensorineural hearing loss, unspecified	0.000	0.999	0.001
S10.9 Superficial injury of neck, part unspecified	0.001	0.999	0.000

This table lists the top 500 terms ordered by p(effect).

The full results table can be downloaded from this page.

The TreeWAS Database is the result of research conducted at the Oxford Big Data Institute at the University of Oxford.

This research has been conducted using the UK Biobank Resource (application number 10625). This work uses data provided by patients and collected by the NHS as part of their care and support.

This research has been conducted with the support of the Wellcome Trust (100956/Z/13/Z and 090532/Z/09/Z and 100308/Z/12/Z), the Danish National Research Foundation, Takeda, the Medical Research Council (MC_UU_12010/3), the Oak Foundation (OCAY-15-520), the National Institute for Health Research (NIHR) Oxford Biomedical Research Centre (BRC), the Wellcome Trust/Royal Society (204290/Z/16/Z) and the Li Ka Shing Foundation.

Variant-specific associations